Search research articles
Contact Us
Filters
Showing results (141-150 of 183) with videos related to
Page
of 19
Sort By:
Scientific Reports
|
September 30, 2023
Memory-efficient low-compute segmentation algorithms for bladder-monitoring smart ultrasound devices
Zhiye Song, Mercy Asiedu, Shuhang Wang, et al.
Cancer Immunology Research
|
November 14, 2019
TCR Repertoire Diversity of Peripheral PD-1<sup>+</sup>CD8<sup>+</sup> T Cells Predicts Clinical Outcomes after Immunotherapy in Patients with Non-Small Cell Lung Cancer
Jiefei Han, Jianchun Duan, Hua Bai, et al.
NPJ Precision Oncology
|
January 14, 2022
Genomic features and tumor immune microenvironment alteration in NSCLC treated with neoadjuvant PD-1 blockade
Shuhang Wang, Pei Yuan, Beibei Mao, et al.
The Lancet. Oncology
|
November 3, 2022
Accelerating the integration of China into the global development of innovative anticancer drugs
Huiyao Huang, Dawei Wu, Huilei Miao, et al.
Cancer Letters
|
June 2, 2024
Exosome-based anticancer vaccines: From Bench to bedside
Guo Zhao, Yuning Wang, Shujun Xing, et al.
Frontiers in Oncology
|
May 7, 2020
Comprehensive Genomic Profiling of Rare Tumors: Routes to Targeted Therapies
Shuhang Wang, Rongrong Chen, Yu Tang, et al.
Cancer Letters
|
October 23, 2018
Transbronchoscopic patient biopsy-derived xenografts as a preclinical model to explore chemorefractory-associated pathways and biomarkers for small-cell lung cancer
Zhijie Wang, Shuai Fu, Jun Zhao, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 27, 2024
Toward a comprehensive solution for treating solid tumors using T-cell receptor therapy: A review
Peiwen Ma, Yale Jiang, Guo Zhao, et al.
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer
|
January 18, 2020
[Awareness and Influencing Factors of Clinical Trial Among Cancer Patients in China]
Huiyao Huang, Yuan Fang, Hong Fang, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
March 4, 2023
Efficacy, Safety, and Biomarker Analysis of Neoadjuvant Camrelizumab and Apatinib in Patients With Resectable NSCLC: A Phase 2 Clinical Trial
Jun Zhao, Liang Zhao, Wei Guo, et al.
Page
of 19
Search research articles
Search
Showing results (141-150 of 183) with videos related to
Sort By:
Page
of 19
Scientific Reports
|
September 30, 2023
Memory-efficient low-compute segmentation algorithms for bladder-monitoring smart ultrasound devices
Zhiye Song, Mercy Asiedu, Shuhang Wang, et al.
Cancer Immunology Research
|
November 14, 2019
TCR Repertoire Diversity of Peripheral PD-1<sup>+</sup>CD8<sup>+</sup> T Cells Predicts Clinical Outcomes after Immunotherapy in Patients with Non-Small Cell Lung Cancer
Jiefei Han, Jianchun Duan, Hua Bai, et al.
NPJ Precision Oncology
|
January 14, 2022
Genomic features and tumor immune microenvironment alteration in NSCLC treated with neoadjuvant PD-1 blockade
Shuhang Wang, Pei Yuan, Beibei Mao, et al.
The Lancet. Oncology
|
November 3, 2022
Accelerating the integration of China into the global development of innovative anticancer drugs
Huiyao Huang, Dawei Wu, Huilei Miao, et al.
Cancer Letters
|
June 2, 2024
Exosome-based anticancer vaccines: From Bench to bedside
Guo Zhao, Yuning Wang, Shujun Xing, et al.
Frontiers in Oncology
|
May 7, 2020
Comprehensive Genomic Profiling of Rare Tumors: Routes to Targeted Therapies
Shuhang Wang, Rongrong Chen, Yu Tang, et al.
Cancer Letters
|
October 23, 2018
Transbronchoscopic patient biopsy-derived xenografts as a preclinical model to explore chemorefractory-associated pathways and biomarkers for small-cell lung cancer
Zhijie Wang, Shuai Fu, Jun Zhao, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 27, 2024
Toward a comprehensive solution for treating solid tumors using T-cell receptor therapy: A review
Peiwen Ma, Yale Jiang, Guo Zhao, et al.
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer
|
January 18, 2020
[Awareness and Influencing Factors of Clinical Trial Among Cancer Patients in China]
Huiyao Huang, Yuan Fang, Hong Fang, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
March 4, 2023
Efficacy, Safety, and Biomarker Analysis of Neoadjuvant Camrelizumab and Apatinib in Patients With Resectable NSCLC: A Phase 2 Clinical Trial
Jun Zhao, Liang Zhao, Wei Guo, et al.
Page
of 19